3 Aug 2026, 17:59 UTC95 views4 reactionsread 8 August 2026 Photo
No Intramuscular Vitamin K Shot at Birth Linked to Higher Bleeding Risk in Infants
▫️The Proportion of Infants With Undocumented Intramuscular Vitamin K Administration at Birth in Sweden Decreased Initially But Increased From 0.66% in 2006 to 1.50% in 2021.
▫️Infants Who Did Not Receive This Prophylaxis Had Increased Odds of Bleeding And Intracranial Hemorrhage Within The First 6 Months of Life, With Oral Vitamin K …
👌3❤1
3 Aug 2026, 17:59 UTC86 views3 reactionsread 8 August 2026 Photo
EC Approved Datroway As First-Line Metastatic Triple-Negative Breast Cancer
▫️AstraZeneca And Japanese Partner Daiichi Sankyo’s Datroway (Datopotamab Deruxtecan) Has Been Approved by The European Commission (EC) As Monotherapy For The 1st-Line Treatment of Adult Patients With Unresectable or Metastatic Triple-Negative Breast Cancer (TNBC) Who Are Not Candidates For PD-1/PD-L1 Inhibitor Therapy.
▫️The Antibody-Drug C…
❤3
3 Aug 2026, 17:59 UTC78 views3 reactionsread 8 August 2026 Photo
FDA Approved Gedatolisib For Hormone Receptor-Positive Breast Cancer
▫️The FDA Has Approved Gedatolisib (Revtorpyk) Plus Fulvestrant (Faslodex), With or Without Palbociclib (Ibrance), For The Treatment of Adult Patients With Hormone Receptor–Positive, HER2-Negative Advanced Breast Cancer Without A PIK3CA Mutation Following Progression On or After Treatment With 1 or More Lines of Endocrine Therapy in The Metastatic …
❤2🙏1
3 Aug 2026, 17:59 UTC72 views4 reactionsread 8 August 2026 Photo
EC Approved Opzelura For Moderate Atopic Dermatitis
▫️The European Commission (EC) Has Approved Opzelura (Ruxolitinib) Cream For The Treatment of Moderate Atopic Dermatitis (AD) in Adult Patients For Whom Topical Corticosteroids (TCSs) And Topical Calcineurin Inhibitors (TCIs) Are Inadequate or Inappropriate, US Biopharma Incyte Announced.
@MedicalNoteBook
❤3👍1
2 Aug 2026, 21:53 UTC72 views4 reactionsread 8 August 2026 Photo
EC Expands Crysvita Approval to Infants With Rare Phosphate Disorder
▫️The European Commission (EC) Has Approved An Expanded Indication For Japan-Based Pharma Company Kyowa Kirin’s Crysvita (Burosumab), Allowing The Medicine to Be Used in Infants From One Month to Under One Year of Age With X-Linked Hypophosphatemia (XLH).
▫️This Decision Follows A Positive Opinion From The European Medicines Agency’s Committee For …
❤3🙏1
2 Aug 2026, 21:49 UTC54 views4 reactionsread 8 August 2026 Photo
FDA Approved First NDSRI For ADHD in Adults And Children
▫️The FDA Has Approved Centanafadine (Simtriyo, Otsuka) As A First-in-Class Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Adult And Pediatric Patients.
▫️The Once-Daily Extended-Release Capsule Is Approved For Adults And Children Aged 6 Years And Older Who Weigh at Least 2 0kg (44.1 lb). It Is The Only Norepinephrine, Dopamine, Serotonin Reup…
❤3👍1
2 Aug 2026, 21:48 UTC49 views4 reactionsread 8 August 2026 Photo
Early-Life Respiratory Infection Burden Linked to Higher Childhood Atopic Dermatitis Risk
▫️Children With A High Burden of Infections Through Age 3 Showed A Greater Risk of Developing Atopic Dermatitis (AD) in A Large Danish Cohort Study.
▫️The Study Was Published Online On July 29 in JAMA Dermatology.
@MedicalNoteBook
❤3👍1
2 Aug 2026, 21:31 UTC45 views4 reactionsread 8 August 2026 Photo
FDA Approved New Once-Weekly Birth Control Patch Gwyn Lo
▫️The FDA Has Approved Gwyn Lo (Viatris), A New Birth Control Patch That Uses Low-dose Estrogen to Prevent Pregnancy.
▫️The Patch Is Designed For Once-Weekly Administration And Delivers The Hormones Norelgestromin (220 μg/day) And Ethinyl Estradiol (20 μg/day) Directly Through The Skin. It Is Applied Once Weekly For 3 Consecutive Weeks, Followed by 1 Patch-Fre…
👌3👍1
2 Aug 2026, 21:31 UTC46 views4 reactionsread 8 August 2026 Photo
Ischemic Heart Disease And Cerebrovascular Disease Linked to Increased Parkinson's Disease
▫️Women With Prior Ischemic Heart Disease (IHD) or Cerebrovascular Disease Had A Higher Long-Term Risk For Parkinson's Disease (PD) in A Study.
▫️It Was Published Online on July 24 in Annals of Clinical and Translational Neurology.
@MedicalNoteBook
❤3👍1
2 Aug 2026, 21:30 UTC44 views4 reactionsread 8 August 2026 Photo
Magic Mushrooms May Reshape The Brain Long After The Trip Ends
▫️A Single dose of Psilocybin, The Psychedelic Substance in Magic Mushrooms, May Produce Physical Changes in The Brain That Remain Detectable For As Long As A Month, According to Researchers at UC San Francisco And Imperial College London.
▫️The Study, Published in Nature Communications, Involved Healthy Adults Who Had Never Previously Used A Psychedelic…
❤3🙏1
2 Aug 2026, 21:30 UTC59 views4 reactionsread 8 August 2026 Photo
FDA Approved First-Ever Freeze-Dried Plasma Product
▫️The US Food And Drug Administration (FDA) On Wednesday Licensed The Nation’s First Freeze-Dried Plasma Product For Transfusion, Clearing The Way For Its Use in Military Operations, Disaster Areas And Other Locations Where Conventional Frozen Plasma Is Unavailable.
▫️The Product, Known As Ezplaz Freeze Dried Plasma, Is Intended For Transfusion in Adult Patients Wh…
👌3👍1
7 Jul 2026, 16:29 UTC218 views5 reactionsread 8 August 2026 Photo
EC Approved Novartis’ Itvisma to Treat SMA
▫️The European Commission (EC) Has Granted Approval For Novartis’ Itvisma (Onasemnogene Abeparvovec) As A Treatment For Children Two Years And Older, Teenagers And Adults Who Have 5q Spinal Muscular Atrophy (SMA) With A Bi-Allelic Mutation in The Survival Motor Neuron 1 (SMN1) Gene.
▫️With This Decision, Itvisma Becomes The Only Gene Replacement Therapy Which Is Currently A…
❤4👍1
Showing the 12 most recent of 20 posts we hold for @MedicalnoteBook. View and reaction counts are the latest single reading for each post, not a live figure, and a recent post is still accumulating both. A view count marked ≈ was rounded by Telegram before we ever saw it — t.me prints views in full below 1,000 and to three significant figures above, so ≈1,200,000 means somewhere between 1,150,000 and 1,249,999. Unmarked counts are exact. Text is reproduced from the public post preview and truncated for length.